Ribelli, Marta
 Distribuzione geografica
Continente #
NA - Nord America 107
EU - Europa 95
AS - Asia 12
AF - Africa 3
Totale 217
Nazione #
US - Stati Uniti d'America 107
SE - Svezia 33
IT - Italia 31
DE - Germania 7
IE - Irlanda 7
CZ - Repubblica Ceca 5
FR - Francia 5
SG - Singapore 5
CN - Cina 4
BE - Belgio 3
CI - Costa d'Avorio 3
IR - Iran 2
RU - Federazione Russa 2
FI - Finlandia 1
GB - Regno Unito 1
IN - India 1
Totale 217
Città #
Chandler 43
Cattolica 16
Ashburn 14
Dublin 7
Brno 5
Marseille 5
Boston 4
Bremen 4
Princeton 4
San Mateo 4
Abidjan 3
Boardman 3
Brussels 3
Milan 3
Rocca Massima 3
Singapore 3
Kish 2
Wilmington 2
Cervignano del Friuli 1
Fairfield 1
Helsinki 1
London 1
Los Angeles 1
Moscow 1
Munich 1
Norwalk 1
Novokuznetsk 1
Nuoro 1
Palermo 1
Woodbridge 1
Totale 140
Nome #
Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory “FoRECATT” study 67
The impact of the multidisciplinary tumor board (MDTB) on the management of pancreatic diseases in a tertiary referral center 63
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 50
Oncogene-addicted non-small-cell lung cancer: Treatment opportunities and future perspectives 45
Totale 225
Categoria #
all - tutte 1.166
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.166


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 0 0 0 0 3 7 1
2021/202257 21 0 0 9 0 1 0 6 1 1 7 11
2022/2023106 11 15 14 22 4 14 8 4 10 0 0 4
2023/202445 0 12 2 3 1 0 5 6 1 3 6 6
2024/20256 6 0 0 0 0 0 0 0 0 0 0 0
Totale 225